Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Proctor & Gamble has found itself under scrutiny by the Federal Drug Administration today. The FDA notified the company that two of its Vicks-branded over-the-counter medications—Vicks DayQuil Plus Vitamin C and Vicks Nyquil Plus Vitamin C—had been marketed illegally.
In the warning letter, the FDA called to attention the fact that P&G’s marketing repeatedly touted the products as both a cold medication as well as a dietary supplement—which is against FDA regulations.
Its marketing says the product works by “[c]ombining the powerful multi-symptom relief of DayQuil with more than 150% of the recommended value of vitamin C.”
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in